Literature DB >> 29287847

Targeted next generation sequencing identified a novel mutation in MYO7A causing Usher syndrome type 1 in an Iranian consanguineous pedigree.

Daniz Kooshavar1, Masoumeh Razipour1, Morteza Movasat2, Mohammad Keramatipour3.   

Abstract

BACKGROUND: Usher syndrome (USH) is characterized by congenital hearing loss and retinitis pigmentosa (RP) with a later onset. It is an autosomal recessive trait with clinical and genetic heterogeneity which makes the molecular diagnosis much difficult. In this study, we introduce a pedigree with two affected members with USH type 1 and represent a cost and time effective approach for genetic diagnosis of USH as a genetically heterogeneous disorder.
METHODS: Target region capture in the genes of interest, followed by next generation sequencing (NGS) was used to determine the causative mutations in one of the probands. Then segregation analysis in the pedigree was conducted using PCR-Sanger sequencing.
RESULTS: Targeted NGS detected a novel homozygous nonsense variant c.4513G > T (p.Glu1505Ter) in MYO7A. The variant is segregating in the pedigree with an autosomal recessive pattern.
CONCLUSION: In this study, a novel stop gained variant c.4513G > T (p.Glu1505Ter) in MYO7A was found in an Iranian pedigree with two affected members with USH type 1. Bioinformatic as well as pedigree segregation analyses were in line with pathogenic nature of this variant. Targeted NGS panel was showed to be an efficient method for mutation detection in hereditary disorders with locus heterogeneity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MYO7A; Mutation; Targeted next generation sequencing; Usher syndrome

Mesh:

Substances:

Year:  2017        PMID: 29287847     DOI: 10.1016/j.ijporl.2017.10.022

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  High-throughput sequencing for the molecular diagnosis of Usher syndrome reveals 42 novel mutations and consolidates CEP250 as Usher-like disease causative.

Authors:  Carla Fuster-García; Gema García-García; Teresa Jaijo; Neus Fornés; Carmen Ayuso; Miguel Fernández-Burriel; Ana Sánchez-De la Morena; Elena Aller; José M Millán
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

2.  Identification of Novel Compound Heterozygous Mutations in the GAN Gene of a Chinese Patient Diagnosed With Giant Axonal Neuropathy.

Authors:  Xiaomin Xu; Xiaokai Yang; Zhongliang Su; Hai Wang; Xiaoqing Li; Congcong Sun; Wenhuan Wang; Yao Chen; Chenhui Zhang; Hongping Zhang; Fan Jin; Jiayong Zheng
Journal:  Front Neurosci       Date:  2020-02-25       Impact factor: 4.677

3.  Unraveling the genetic complexities of combined retinal dystrophy and hearing impairment.

Authors:  Fatemeh Suri; Barbara Vona; Thomas Haaf; Paulina Bahena; Narsis Daftarian; Reza Maroofian; Paola Linares; Daniel Villalobos; Mehraban Mirrahimi; Aboulfazl Rad; Julia Doll; Michaela A H Hofrichter; Asuman Koparir; Tabea Röder; Seungbin Han; Hamideh Sabbaghi; Hamid Ahmadieh; Hassan Behboudi; Cristina Villanueva-Mendoza; Vianney Cortés-Gonzalez; Rocio Zamora-Ortiz; Susanne Kohl; Laura Kuehlewein; Hossein Darvish; Elham Alehabib; Maria de la Luz Arenas-Sordo
Journal:  Hum Genet       Date:  2021-06-20       Impact factor: 5.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.